Autonomix Medical (AMIX) EV/EBIT: History & Chart

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T12:00:59.251Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:00:59.251Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,922,220
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 3,460,000
TTM operating income · period ending 2026-06-30: -16,384,000

FMP input reference: a397cd850420951a0c9724a6b76f21fabdb26d17d869f1b33831b183cdf643d3

EV/EBITDA|EV/Sales|Operating Income|All Metrics

AMIX EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

AMIX Competitors' EV/EBIT Ratio

AMIX

Autonomix Medical, Inc.

Current

Market Cap

$1.92M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRIS

Curis, Inc.

vs AMIX

Market Cap

$1.54M

EV/EBIT Ratio

N/A

TTM Avg

439.92x

3Y Avg

439.92x

5Y Avg

439.92x

ELAB

PMGC Holdings Inc.

vs AMIX

Market Cap

$1.49M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs AMIX

Market Cap

$2.37M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBLG

FibroBiologics, Inc. Common Stock

vs AMIX

Market Cap

$2.47M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs AMIX

Market Cap

$1.36M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIAF

bioAffinity Technologies, Inc.

vs AMIX

Market Cap

$2.59M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CMND

Clearmind Medicine Inc.

vs AMIX

Market Cap

$1.11M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ASBP

Aspire Biopharma Holdings, Inc.

vs AMIX

Market Cap

$1.02M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCOY

Decoy Therapeutics Inc.

vs AMIX

Market Cap

$888387.00

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Autonomix Medical, Inc. (AMIX)	$1.92M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.54M	N/A	439.92x	439.92x	439.92x
PMGC Holdings Inc. (ELAB)vs ›	$1.49M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.37M	N/A	N/A	N/A	N/A
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.47M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.36M	N/A	N/A	N/A	N/A
bioAffinity Technologies, Inc. (BIAF)vs ›	$2.59M	N/A	N/A	N/A	N/A
Clearmind Medicine Inc. (CMND)vs ›	$1.11M	N/A	N/A	N/A	N/A
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.02M	N/A	N/A	N/A	N/A
Decoy Therapeutics Inc. (DCOY)vs ›	$888387.00	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

AMIX EV/EBIT Ratio Metrics

AMIX Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics